Invesco’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.31M | Buy |
383,316
+35,773
| +10% | +$119K | ﹤0.01% | 2783 |
|
|
2026
Q1 | $1.24M | Buy |
347,543
+43,106
| +14% | +$171K | ﹤0.01% | 2765 |
|
|
2025
Q4 | $1.07M | Buy |
304,437
+81,984
| +37% | +$281K | ﹤0.01% | 2882 |
|
|
2025
Q3 | $725K | Buy |
222,453
+111,449
| +100% | +$351K | ﹤0.01% | 3078 |
|
|
2025
Q2 | $272K | Sell |
111,004
-289,965
| -72% | -$1.47M | ﹤0.01% | 3406 |
|
|
2025
Q1 | $2.67M | Buy |
400,969
+43,129
| +12% | +$426K | ﹤0.01% | 2426 |
|
|
2024
Q4 | $4.5M | Buy |
357,840
+5,218
| +1% | +$78.5K | ﹤0.01% | 2307 |
|
|
2024
Q3 | $6.51M | Buy |
352,622
+596
| +0.2% | +$12.2K | ﹤0.01% | 2069 |
|
|
2024
Q2 | $7.58M | Buy |
352,026
+310,836
| +755% | +$7.14M | ﹤0.01% | 1966 |
|
|
2024
Q1 | $1.11M | Sell |
41,190
-55,653
| -57% | -$1.58M | ﹤0.01% | 2944 |
|
|
2023
Q4 | $2.9M | Buy |
96,843
+42,915
| +80% | +$947K | ﹤0.01% | 2479 |
|
|
2023
Q3 | $1.1M | Sell |
53,928
-103,151
| -66% | -$1.87M | ﹤0.01% | 2817 |
|
|
2023
Q2 | $3.12M | Buy |
157,079
+116,284
| +285% | +$2.35M | ﹤0.01% | 2467 |
|
|
2023
Q1 | $699K | Sell |
40,795
-67,582
| -62% | -$1.32M | ﹤0.01% | 3090 |
|
|
2022
Q4 | $2.12M | Buy |
108,377
+72,819
| +205% | +$1.34M | ﹤0.01% | 2626 |
|
|
2022
Q3 | $567K | Sell |
35,558
-1,225
| -3% | -$19.1K | ﹤0.01% | 3189 |
|
|
2022
Q2 | $506K | Buy |
36,783
+1,528
| +4% | +$18.2K | ﹤0.01% | 3321 |
|
|
2022
Q1 | $558K | Buy |
35,255
+16,749
| +91% | +$289K | ﹤0.01% | 3334 |
|
|
2021
Q4 | $405K | Sell |
18,506
-2,849
| -13% | -$77.7K | ﹤0.01% | 3480 |
|
|
2021
Q3 | $638K | Sell |
21,355
-176,462
| -89% | -$6.42M | ﹤0.01% | 3315 |
|
|
2021
Q2 | $8.76M | Sell |
197,817
-83,957
| -30% | -$3.65M | ﹤0.01% | 2139 |
|
|
2021
Q1 | $12.5M | Sell |
281,774
-258,294
| -48% | -$14.2M | ﹤0.01% | 1832 |
|
|
2020
Q4 | $29.6M | Buy |
540,068
+120,643
| +29% | +$4.4M | 0.01% | 1229 |
|
|
2020
Q3 | $9.59M | Buy |
419,425
+768
| +0.2% | +$18.9K | ﹤0.01% | 1675 |
|
|
2020
Q2 | $8.76M | Sell |
418,657
-162,647
| -28% | -$2.93M | ﹤0.01% | 1709 |
|
|
2020
Q1 | $8.11M | Sell |
581,304
-3,094
| -0.5% | -$61.3K | ﹤0.01% | 1633 |
|
|
2019
Q4 | $13.3M | Sell |
584,398
-5,474
| -0.9% | -$91.4K | ﹤0.01% | 1610 |
|
|
2019
Q3 | $6.87M | Hold |
589,872
| – | – | ﹤0.01% | 1946 |
|
|
2019
Q2 | $8.85M | Buy |
589,872
+4
| +0% | +$70 | ﹤0.01% | 1828 |
|
|
2019
Q1 | $10.3M | Sell |
589,868
-367
| -0.1% | -$5.79K | ﹤0.01% | 1548 |
|
|
2018
Q4 | $8.75M | Buy |
590,235
+113,195
| +24% | +$1.88M | ﹤0.01% | 1603 |
|
|
2018
Q3 | $11.7M | Buy |
477,040
+380,310
| +393% | +$8.25M | ﹤0.01% | 1609 |
|
|
2018
Q2 | $1.9M | Buy |
+96,730
| New | +$1.83M | ﹤0.01% | 2798 |
|
Other funds holding RCKT
RI
NM
MC
Invesco's RCKT Position: Q2 2026 in Review
Invesco increased its Rocket Pharmaceuticals (RCKT) stake by 10% in Q2 2026, buying an estimated $119K and bringing the position to 383,316 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2783.
Invesco first reported a position in RCKT in Q2 2018 and has held it in 33 quarters since. The position peaked at $29.6M in Q4 2020. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.
- Invesco held 383,316 shares of Rocket Pharmaceuticals worth $1.31M as of Q2 2026.
- Invesco bought 35,773 Rocket Pharmaceuticals shares in Q2 2026, an estimated $119K.
- Rocket Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2783 holding.
- Invesco first reported a position in Rocket Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- Invesco's Rocket Pharmaceuticals position peaked at $29.6M in Q4 2020.
- 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.